1. Home
  2. NVR vs ROIV Comparison

NVR vs ROIV Comparison

Compare NVR & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NVR Inc.

NVR

NVR Inc.

HOLD

Current Price

$7,020.74

Market Cap

17.9B

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$29.25

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVR
ROIV
Founded
1980
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.9B
20.7B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
NVR
ROIV
Price
$7,020.74
$29.25
Analyst Decision
Hold
Strong Buy
Analyst Count
5
9
Target Price
$7,347.80
$28.94
AVG Volume (30 Days)
15.3K
4.2M
Earning Date
04-23-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
436.55
N/A
Revenue
$10,323,959,000.00
$29,053,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.60
$744.61
P/E Ratio
$16.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6,301.03
$10.58
52 Week High
$8,618.28
$30.33

Technical Indicators

Market Signals
Indicator
NVR
ROIV
Relative Strength Index (RSI) 56.81 57.91
Support Level $6,301.03 $20.46
Resistance Level $7,735.76 $30.33
Average True Range (ATR) 177.49 0.85
MACD 66.91 0.10
Stochastic Oscillator 63.84 73.60

Price Performance

Historical Comparison
NVR
ROIV

About NVR NVR Inc.

NVR Inc is engaged in the construction and sale of residential properties, including single-family detached homes, townhomes, and condominium buildings, all of which are built on a pre-sold basis. Additionally, the company provides related services through its mortgage banking and title services businesses. Its business segments are Homebuilding and Mortgage Banking. Its geographical segments include the Mid Atlantic, the North East, the Mid East, and the South East regions of America. The majority of the company's revenue is derived from the Homebuilding Mid Atlantic segment, which includes homebuilding operations that construct and sell single-family detached homes, townhomes and condominiums in Maryland, Virginia, West Virginia, Delaware and Washington, D.C. regions.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: